W. Paska

1.1k total citations
17 papers, 805 citations indexed

About

W. Paska is a scholar working on Surgery, Psychiatry and Mental health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, W. Paska has authored 17 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 4 papers in Psychiatry and Mental health and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in W. Paska's work include Nausea and vomiting management (6 papers), Bipolar Disorder and Treatment (4 papers) and Pharmacological Effects and Toxicity Studies (3 papers). W. Paska is often cited by papers focused on Nausea and vomiting management (6 papers), Bipolar Disorder and Treatment (4 papers) and Pharmacological Effects and Toxicity Studies (3 papers). W. Paska collaborates with scholars based in United Kingdom, Canada and France. W. Paska's co-authors include John A. Ascher, K. Behnke, Lakshmi N. Yatham, Gary Sachs, Charles L. Bowden, Paul Montgomery, O.‐P. Mehtonen, Joseph DeVeaugh-Geiss, Nancy L. Earl and Joseph R. Calabrese and has published in prestigious journals such as Annals of Oncology, Alimentary Pharmacology & Therapeutics and The Journal of Clinical Psychiatry.

In The Last Decade

W. Paska

17 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Paska United Kingdom 8 457 223 172 91 75 17 805
Wen Xu United States 16 456 1.0× 27 0.1× 99 0.6× 68 0.7× 144 1.9× 40 1.1k
Alan Moore Switzerland 13 528 1.2× 156 0.7× 503 2.9× 136 1.5× 5 0.1× 28 1.0k
Thorsten Gerstner Germany 11 228 0.5× 73 0.3× 365 2.1× 18 0.2× 18 0.2× 28 684
Philip H. Sheridan United States 11 227 0.5× 61 0.3× 358 2.1× 48 0.5× 17 0.2× 21 658
Mustafa Büyükavcı Türkiye 13 38 0.1× 90 0.4× 102 0.6× 18 0.2× 16 0.2× 53 526
Martin Johnson United States 17 932 2.0× 70 0.3× 898 5.2× 177 1.9× 5 0.1× 30 1.3k
Gopi Menon United Kingdom 12 47 0.1× 67 0.3× 184 1.1× 35 0.4× 7 0.1× 22 488
Eduardo dos Santos Paiva Brazil 12 155 0.3× 58 0.3× 22 0.1× 67 0.7× 22 0.3× 43 489
Patrick Martin United States 15 175 0.4× 98 0.4× 58 0.3× 50 0.5× 23 0.3× 40 561
Fred Schobben Netherlands 8 120 0.3× 24 0.1× 215 1.3× 20 0.2× 35 0.5× 14 524

Countries citing papers authored by W. Paska

Since Specialization
Citations

This map shows the geographic impact of W. Paska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Paska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Paska more than expected).

Fields of papers citing papers by W. Paska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Paska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Paska. The network helps show where W. Paska may publish in the future.

Co-authorship network of co-authors of W. Paska

This figure shows the co-authorship network connecting the top 25 collaborators of W. Paska. A scholar is included among the top collaborators of W. Paska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Paska. W. Paska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Boyle, Julia, John A. Groeger, W. Paska, et al.. (2012). A Method to Assess the Dissipation of the Effects of Residual Hypnotics. Journal of Clinical Psychopharmacology. 32(5). 704–709. 14 indexed citations
2.
Geddes, John, et al.. (2007). Lamotrigine for acute treatment of bipolar depression: individual patient data meta-analysis of 5 randomized, placebo-controlled trials. Bipolar Disorders. 9. 42–43. 3 indexed citations
3.
Geddes, John, et al.. (2006). Lamotrigine for acute treatment of bipolar depression: Additional clinical trial data and a retrospective pooled analysis of response rates across all randomized trials conducted by GSK. Bipolar Disorders. 8. 32–32. 4 indexed citations
4.
Calabrese, Joseph R., Charles L. Bowden, Gary Sachs, et al.. (2003). A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Depressed Patients With Bipolar I Disorder. The Journal of Clinical Psychiatry. 64(9). 1013–1024. 454 indexed citations
5.
Bowden, C.L., J.R. Calabrese, K. Behnke, et al.. (2002). Lamotrigine delays mood episodes in recently depressed bipolar I patients. European Neuropsychopharmacology. 12. 216–217. 7 indexed citations
6.
Emsley, Robin, S. Brook, Sophia Frangou, et al.. (2001). Safety and tolerability of lamotrigine in controlled mood disorder trials. European Neuropsychopharmacology. 11. S204–S205. 3 indexed citations
7.
Behnke, K., O.‐P. Mehtonen, S. Rasmussen, et al.. (2001). Lamotrigine: Evidence for mood stabilization in bipolar I depression. European Neuropsychopharmacology. 11. S205–S205. 1 indexed citations
8.
Davidson, Neville, Bernardo L. Rapoport, Björn Erikstein, et al.. (1999). Comparison of an orally disintegrating ondansetron tablet with the conventional ondansetron tablet for cyclophosphamide-induced emesis in cancer patients: A multicenter, double-masked study. Clinical Therapeutics. 21(3). 492–502. 25 indexed citations
10.
Cubeddu, Luigi X., et al.. (1997). Antiemetic activity of ondansetron in acute gastroenteritis. Alimentary Pharmacology & Therapeutics. 11(1). 185–191. 72 indexed citations
11.
Olver, Ian, W. Paska, A Depierre, et al.. (1996). A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Annals of Oncology. 7(9). 945–952. 61 indexed citations
12.
Ruff, Paul, W. Paska, L. Goedhals, et al.. (1994). Ondansetron Compared with Granisetron in the Prophylaxis of Cisplatin-lnduced Acute Emesis: A Multicentre Double-Blind, Randomised, Parallel-Group Study. Oncology. 51(1). 113–118. 90 indexed citations
13.
Räth, U., B.K. Upadhyaya, Hannes Böckmann, et al.. (1993). Role of Ondansetron plus Dexamethasone in Fractionated Chemotherapy. Oncology. 50(3). 168–172. 23 indexed citations
14.
Paska, W. & Kylie McDonald. (1988). Induction of a silica air-pouch granuloma in rat. Inflammation Research. 24(3-4). 283–291. 2 indexed citations
15.
Paska, W., et al.. (1986). Studies on type II collagen induced arthritis in mice. Inflammation Research. 18(3-4). 413–420. 39 indexed citations
16.
Paska, W., et al.. (1979). Reaginic antibodies and the dextran reaction in the rat. Inflammation Research. 9(1). 92–93. 2 indexed citations
17.
Paska, W., et al.. (1979). IgE production in two types of genetically different rats.. PubMed. 14. 27–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026